Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Antimalarial t-butylperoxyamines.

N Sundar1, V T Jacob, S V Bhat

  • 1Department of Chemistry, Indian Institute of Technology, Powai, Bombay 400 076, India.

Bioorganic & Medicinal Chemistry Letters
|August 31, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Comprehensive case management of malaria: Operational research informing policy.

Journal of vector borne diseases·2019
Same author

Expert Group Meeting on Aphasia: A Report.

Annals of Indian Academy of Neurology·2019
Same author

Craniopharyngeal duct: a cause of recurrent meningitis.

BJR case reports·2018
Same author

Small-scale (Phase II) evaluation of the efficacy and residual activity of SumiShield<sup>®</sup> 50 WG (clothianidin 50%, w/w) for indoor residual spraying in comparison to deltamethrin, bendiocarb and pirimiphos-methyl for malaria vector control in Karnataka state, India.

Journal of vector borne diseases·2018
Same author

Neuroradiological findings in patients with "non-lesional" focal epilepsy revealed by research protocol.

Clinical radiology·2018
Same author

Effective in Vivo Targeting of Influenza Virus through a Cell-Penetrating/Fusion Inhibitor Tandem Peptide Anchored to the Plasma Membrane.

Bioconjugate chemistry·2018
Same journal

Discovery of a potent sGC stimulator with once-daily dosing potential for the treatment of hypertension.

Bioorganic & medicinal chemistry letters·2026
Same journal

OracleScreen-LILRB4 (HTS-Oracle v3): machine learning-guided discovery of myeloid immune checkpoint binders validated in patient-derived cells.

Bioorganic & medicinal chemistry letters·2026
Same journal

Rational design and N-terminal acylation of a lactam-cyclized 11-residue antimicrobial peptide for improved antibacterial potency.

Bioorganic & medicinal chemistry letters·2026
Same journal

Rational design, synthesis, and biological evaluation of chalcone hybrids including benzoylpiperazin (phenylacetylpiperazin)-thiophene as anti- Alzheimer's agents.

Bioorganic & medicinal chemistry letters·2026
Same journal

New aminopiperidine-azoles as antifungal agents against Candida albicans with mechanistic insights into the cAMP-PKA pathway.

Bioorganic & medicinal chemistry letters·2026
Same journal

Novel 1H-pyrrole-2,5-dione derivatives as potential anti-diabetic agents: design, synthesis, in vitro, in ovo, and molecular docking studies.

Bioorganic & medicinal chemistry letters·2026
See all related articles

Twelve novel t-butylperoxyamines were synthesized and tested as antimalarial drugs. Compound 8 showed the most potent activity in vivo against malaria parasites in mice, while compound 11 was most effective in vitro.

Area of Science:

  • Medicinal Chemistry
  • Parasitology
  • Drug Discovery

Background:

  • Malaria remains a significant global health threat, necessitating the development of new antimalarial drugs.
  • Drug resistance in Plasmodium falciparum complicates treatment strategies.
  • T-butylperoxyamines represent a novel chemical class for antimalarial drug development.

Purpose of the Study:

  • To synthesize novel t-butylperoxyamine compounds.
  • To evaluate the antimalarial activity of these compounds in vitro and in vivo.
  • To identify lead compounds for further antimalarial drug development.

Main Methods:

  • Synthesis of twelve t-butylperoxyamine analogs (compounds 6-17).
  • In vivo antimalarial testing against Plasmodium berghei in mice.

Related Experiment Videos

  • In vitro antimalarial testing against chloroquine-sensitive and chloroquine-resistant Plasmodium falciparum strains.

    • Main Results:

    • Compound 8 demonstrated significant in vivo antimalarial activity at doses of 80 and 160 mg/kg.
    • Compound 11 exhibited the highest in vitro efficacy against Plasmodium falciparum strains.
    • Compounds 6-17 displayed varying degrees of antimalarial activity.

    Conclusions:

    • T-butylperoxyamines are a promising scaffold for developing new antimalarial agents.
    • Compound 8 and compound 11 are identified as lead candidates for further investigation.
    • Further studies are warranted to optimize these compounds and assess their safety and efficacy.